Luca Beltrame
Luca Beltrame
Senior Bioinformatician, IRCCS Humanitas Research Hospital
Verified email at
Cited by
Cited by
Role of macrophage targeting in the antitumor activity of trabectedin
G Germano, R Frapolli, C Belgiovine, A Anselmo, S Pesce, M Liguori, ...
Cancer cell 23 (2), 249-262, 2013
Blood pressure variability and organ damage in a general population: results from the PAMELA study
R Sega, G Corrao, M Bombelli, L Beltrame, R Facchetti, G Grassi, ...
Hypertension 39 (2), 710-714, 2002
Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections
S Marchini, D Cavalieri, R Fruscio, E Calura, D Garavaglia, IF Nerini, ...
The lancet oncology 12 (3), 273-285, 2011
Pharmacological blockade of IL-1β/IL-1 receptor type 1 axis during epileptogenesis provides neuroprotection in two rat models of temporal lobe epilepsy
FM Noe, N Polascheck, F Frigerio, M Bankstahl, T Ravizza, S Marchini, ...
Neurobiology of disease 59, 183-193, 2013
Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer
S Marchini, R Fruscio, L Clivio, L Beltrame, L Porcu, IF Nerini, D Cavalieri, ...
European journal of cancer 49 (2), 520-530, 2013
Blockade of the IL-1R1/TLR4 pathway mediates disease-modification therapeutic effects in a model of acquired epilepsy
V Iori, AM Iyer, T Ravizza, L Beltrame, L Paracchini, S Marchini, M Cerovic, ...
Neurobiology of disease 99, 12-23, 2017
Mode of action of trabectedin in myxoid liposarcomas
S Di Giandomenico, R Frapolli, E Bello, S Uboldi, SA Licandro, S Marchini, ...
Oncogene 33 (44), 5201-5210, 2014
Rarity of human T helper 17 cells is due to retinoic acid orphan receptor-dependent mechanisms that limit their expansion
V Santarlasci, L Maggi, M Capone, V Querci, L Beltrame, D Cavalieri, ...
Immunity 36 (2), 201-214, 2012
Inhibition of immune synapse by altered dendritic cell actin distribution: a new pathway of mesenchymal stem cell immune regulation
A Aldinucci, L Rizzetto, L Pieri, D Nosi, P Romagnoli, T Biagioli, ...
The Journal of Immunology 185 (9), 5102-5110, 2010
Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models
C Belgiovine, E Bello, M Liguori, I Craparotta, L Mannarino, L Paracchini, ...
British Journal of Cancer 117 (5), 628-638, 2017
Bone marrow fibroblasts overexpress miR‐27b and miR‐214 in step with multiple myeloma progression, dependent on tumour cell‐derived exosomes
MA Frassanito, V Desantis, L Di Marzo, I Craparotta, L Beltrame, ...
The Journal of Pathology 247 (2), 241-253, 2019
IL‐4‐induced gene 1 maintains high T ob1 expression that contributes to TCR unresponsiveness in human T helper 17 cells
V Santarlasci, L Maggi, A Mazzoni, M Capone, V Querci, MC Rossi, ...
European journal of immunology 44 (3), 654-661, 2014
Genome-wide screening of copy number alterations and LOH events in renal cell carcinomas and integration with gene expression profile
I Cifola, R Spinelli, L Beltrame, C Peano, E Fasoli, S Ferrero, S Bosari, ...
Molecular cancer 7 (1), 1-12, 2008
The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus
R Vįzquez, ME Riveiro, L Astorgues-Xerri, E Odore, K Rezai, E Erba, ...
Oncotarget 8 (5), 7598, 2017
MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities
E Calura, R Fruscio, L Paracchini, E Bignotti, A Ravaggi, P Martini, ...
Clinical cancer research 19 (15), 4114-4123, 2013
Differential IL-17 production and mannan recognition contribute to fungal pathogenicity and commensalism
L Rizzetto, M Kuka, C De Filippo, A Cambi, MG Netea, L Beltrame, ...
The Journal of Immunology 184 (8), 4258-4268, 2010
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts
P Todeschini, E Salviato, L Paracchini, M Ferracin, M Petrillo, L Zanotti, ...
Cancer Letters 388, 320-327, 2017
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective …
M Petrillo, GF Zannoni, L Beltrame, E Martinelli, A DiFeo, L Paracchini, ...
Annals of Oncology 27 (4), 625-634, 2016
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients
RA Tassi, P Todeschini, ER Siegel, S Calza, P Cappella, L Ardighieri, ...
Journal of Experimental & Clinical Cancer Research 36, 1-18, 2017
lncRNAs as novel indicators of patients' prognosis in stage I epithelial ovarian cancer: A retrospective and multicentric study
P Martini, L Paracchini, G Caratti, M Mello-Grand, R Fruscio, L Beltrame, ...
Clinical Cancer Research 23 (9), 2356-2366, 2017
The system can't perform the operation now. Try again later.
Articles 1–20